Epidemiologic trends in HBV infections at a reference centre in Turkey: an 11-year retrospective analysis
Journal Title: Annals of Hepatology - Year 2012, Vol 11, Issue 5
Abstract
Objective. To identify changes in hepatitis B epidemiology after the implementation of the nationwide vaccination program in Turkey, hepatitis B virus (HBV) and related tests performed over a period of 11 years (2000-2010) at a reference centre were retrospectively overviewed and statistically analysed for trends.Results. Assay results for Hepatitis B surface antigen (HBsAg) and e antigen (HBeAg), Anti-HBs, Anti-HBe, Anti-HBc immunoglobulins and HBV DNA as well as aspartate aminotransferase (AST), alanine aminotransferase (ALT), gama-glutamyl transpeptidase (GGT) and alkaline phosphatase (AP) levels, obtained via standardized commercial assays were included in the analysis. Overall, a stable anti-HBs incidence (43.6%) and male predominance in infected individuals were noted. Total Anti-HBc was detected in 43.3% of the Anti-HBs reactive population, demonstrating that the immunity against HBV has still been acquired through virus exposure. An intermediate HBsAg seroprevalence of 6.0% was observed with a significant decrease from 12.3% to 5.0% from 2000 to 2010. Anti-HBe positive infections were more frequent than those with HBe antigenemia (77.1% vs. 18.5%) with a notable increase from 2000 to 2003. HBV DNA was detected in 23.6-25.6% with serological markers of viral replication and was more prevalent in HBeAg positive individuals in parallel with AST, ALT and GGT levels. Evidence for horizontal transfer as the major transmission route was revealed with a reduction of childhood HBV infections, attributable to the ongoing vaccination efforts.
Authors and Affiliations
Koray Ergunay, Yasemin Balaban, Erdal Cosgun, Alpaslan Alp, Halis Simsek, Burcin Sener, Gonca Tatar, Gulsen Hascelik
Keywords
Related Articles
- EP ID EP78189
- DOI -
- Views 160
- Downloads 0
A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients
Purpose. Chronic hepatitis C virus (HCV) is a major problem affecting up to 170 million people worldwide. Two protease inhibitors have recently been approved that will revolutionize treatment. Our objective was to summar...
Hepatolithiasis with secondary cholangitis and supernumerary left hepatic lobe
We report the case of a 31-year old woman with recurrent cholangitis secondary to hepatolithiasis. The stones were composed of calcium bilirrubinate. The patient also had a supernumerary hepatic lobe connected to the inf...
Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding
Aim. To perform an updated meta-analysis comparing β-blockers (BB) with endoscopic variceal banding ligation (EVBL) in the primary prophylaxis of esophageal variceal bleeding. Material and methods. Randomized controlled...
Prevalence and risk factors for bacterial skin infection and mortality in cirrhosis
Background. Bacterial infections are often associated with significant morbidity and mortality in cirrhosis. The common practice of outdoor barefoot walking in the developing world may predispose cirrhotic individuals to...
The unfulfilled promise of efficacy trials in HIV/hepatitis C co-infected patients